<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo2413" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39040523</article-id><article-id pub-id-type="pmc">PMC11260769</article-id>
<article-id pub-id-type="doi">10.1002/deo2.413</article-id><article-id pub-id-type="publisher-id">DEO2413</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Current status of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms</article-title><alt-title alt-title-type="left-running-head">OHNO <sc>et al</sc>.</alt-title></title-group><contrib-group><contrib id="deo2413-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ohno</surname><given-names>Eizaburo</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7730-4630</contrib-id><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>eono@med.nagoya-u.ac.jp</email></address></contrib><contrib id="deo2413-cr-0002" contrib-type="author"><name><surname>Kuzuya</surname><given-names>Teiji</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0003" contrib-type="author"><name><surname>Kawabe</surname><given-names>Naoto</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0004" contrib-type="author"><name><surname>Nakaoka</surname><given-names>Kazunori</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0005" contrib-type="author"><name><surname>Tanaka</surname><given-names>Hiroyuki</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0006" contrib-type="author"><name><surname>Nakano</surname><given-names>Takuji</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0007" contrib-type="author"><name><surname>Funasaka</surname><given-names>Kohei</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0008" contrib-type="author"><name><surname>Miyahara</surname><given-names>Ryoji</given-names></name><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo2413-cr-0009" contrib-type="author"><name><surname>Hashimoto</surname><given-names>Senju</given-names></name><xref rid="deo2413-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo2413-cr-0010" contrib-type="author"><name><surname>Hirooka</surname><given-names>Yoshiki</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9639-7425</contrib-id><xref rid="deo2413-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="deo2413-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology and Hepatology</named-content>
<institution>Fujita Health University School of Medicine</institution>
<city>Aichi</city>
<country country="JP">Japan</country>
</aff><aff id="deo2413-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology and Hepatology</named-content>
<institution>Fujita Health University Bantane Hospital</institution>
<city>Aichi</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Eizaburo Ohno, Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, 1&#x02013;98, Dengakugakubo, Kutsukake&#x02010;Cho, Toyoake, Aichi 470&#x02013;1192, Japan.<break/> Email: <email>eono@med.nagoya-u.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="105">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e413</elocation-id><history>
<date date-type="rev-recd"><day>02</day><month>7</month><year>2024</year></date>
<date date-type="received"><day>02</day><month>5</month><year>2024</year></date>
<date date-type="accepted"><day>06</day><month>7</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e413.pdf"/><abstract><title>Abstract</title><p>The new Kyoto guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) provide evidence&#x02010;based recommendations for the diagnosis and treatment of IPMN. Endoscopic ultrasonography (EUS) is a diagnostic modality with a high spatial resolution that allows detailed observation and obtaining cyst fluid or tissue samples via EUS&#x02010;guided fine needle aspiration (EUS&#x02010;FNA). Currently, EUS is an indispensable examination method for the diagnosis of pancreatic diseases. On the other hand, there have been concerns that EUS imaging tends to be highly operator&#x02010;dependent, and may lack objectivity. Previous guidelines have assigned EUS as an option for patients with worrisome features. However, recent reports indicate that the sensitivity of EUS for the diagnosis of mural nodules (MNs) is more than 90%, comparable or superior to that of contrast&#x02010;enhanced computed tomography or magnetic resonance cholangiopancreatography. The specific advantages of EUS in the diagnosis of IPMN are: (1) high spatial resolution imaging for the diagnosis of MNs, (2) contrast&#x02010;enhanced EUS for differentiation of intra&#x02010;cystic MNs from mucous clots, and (3) pathological diagnosis using EUS&#x02010;FNA and differential diagnosis of a pancreatic cystic tumor by cystic fluid analysis. In order to utilize EUS in the diagnosis of IPMN, endoscopists are required to have the skills to provide sufficiently objective imaging findings.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo2413-kwd-0001">contrast&#x02010;enhanced harmonic EUS</kwd><kwd id="deo2413-kwd-0002">EUS</kwd><kwd id="deo2413-kwd-0003">EUS&#x02010;guided fine needle aspiration</kwd><kwd id="deo2413-kwd-0004">intraductal papillary mucinous neoplasms</kwd><kwd id="deo2413-kwd-0005">mural nodule</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="2"/><page-count count="8"/><word-count count="5248"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo2413-sec-0010"><title>INTRODUCTION</title><p>Intraductal papillary mucinous neoplasm (IPMN) is a pancreatic epithelial neoplasm characterized by mucus production, associated cyst formation, and main duct dilation.<xref rid="deo2413-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Several guidelines have been reported to manage the treatment of IPMN and other pancreatic cystic lesions (PCLs), including international evidence&#x02010;based guidelines (Kyoto Guidelines 2023), guidelines by the European Study Group (2018), and American Gastroenterological Association (2015).<xref rid="deo2413-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo2413-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo2413-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> IPMN is one of the most frequently diagnosed lesions among PCLs. IPMN is an epithelial neoplasm that slowly progresses from adenoma to adenocarcinoma, and the diagnosis of malignancy is presumed based on the morphologic features of IPMN: cyst size, main pancreatic duct (MPD) size, and nodules within the cyst. IPMN is reported to be a &#x0201c;high&#x02010;risk group for pancreatic cancer&#x0201d; because IPMN has the risk of malignant transformation (IPMN&#x02010;derived carcinoma) and the development of concomitant invasive pancreatic ductal carcinoma.<xref rid="deo2413-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>, <xref rid="deo2413-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo2413-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="deo2413-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Endoscopic ultrasonography (EUS) has a high spatial resolution, which allows for a more detailed image than other diagnostic modalities.<xref rid="deo2413-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> EUS&#x02010;guided fine needle aspiration (EUS&#x02010;FNA) was first reported by Vilmann in 1992 and has since been widely used in the pancreaticobiliary field, not only for tissue sampling for pathological diagnosis but also as an essential test for comprehensive genomic profile tests.<xref rid="deo2413-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo2413-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>This work reviews the current role and the usefulness of EUS in the diagnosis of IPMN to date with respect to the following items.
<list list-type="order" id="deo2413-list-0001"><list-item><p>The utility of EUS in distinguishing malignant from benign IPMN compared to other diagnostic modalities.</p></list-item><list-item><p>The advantages of contrast&#x02010;enhanced EUS/contrast&#x02010;enhanced harmonic EUS in IPMN diagnostics.</p></list-item><list-item><p>Pathological diagnosis using EUS&#x02010;FNA and differential diagnosis of pancreatic cystic tumor by cystic fluid analysis.</p></list-item></list>
</p></sec><sec id="deo2413-sec-0020"><title>THE ROLE OF EUS BASED ON THE FORMER INTERNATIONAL CONSENSUS GUIDELINES FOR IPMNs</title><p>The treatment algorithm of the revised Fukuoka guidelines published in 2017 recommended that surgery should be considered in patients with high&#x02010;risk stigmata (HRS) or with worrisome features (WF) on imaging findings, such as the presence of a definitive nodule larger than 5 mm, MPD involvement on EUS findings, or cytology findings of suspicious or positive for malignancy.<xref rid="deo2413-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> EUS is an imaging technique with high spatial resolution, and it is also capable of cytology, histology, and cyst fluid analysis via EUS&#x02010;FNA. However, its role in diagnostic algorithms based on revised Fukuoka guidelines was limited because EUS is not a procedure that can be performed at all institutions with the same quality. In recent years, the usefulness of EUS&#x02010;based imaging and EUS&#x02010;FNA in the diagnosis of IPMN has been widely reported. The Kyoto Guidelines published in 2023 proposed a more prominent role of EUS diagnosis in the management of IPMN and recommended its use in the evaluation of HRS and worrisome features<xref rid="deo2413-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> (Figure&#x000a0;<xref rid="deo2413-fig-0001" ref-type="fig">1</xref>).</p><fig position="float" fig-type="FIGURE" id="deo2413-fig-0001"><label>FIGURE 1</label><caption><p>Diagnostic algorithm of intraductal papillary mucinous neoplasm based on Kyoto guidelines. HGD, high&#x02010;grade dysplasia; IC, invasive carcinoma; MDCT, multidetector computed tomography; MRCP, magnetic resonance cholangiopancreatography; MRI, magnetic resonance imaging.</p></caption><graphic xlink:href="DEO2-5-e413-g001" position="anchor" id="jats-graphic-1"/></fig><sec id="deo2413-sec-0030"><title>The utility of EUS in distinguishing malignant from benign IPMN compared to other diagnostic modalities</title><p>Contrast&#x02010;enhanced CT (CE&#x02010;CT; multidetector computed tomography [MDCT]) and MRI (contrast&#x02010;enhanced MRI/magnetic resonance cholangiopancreatography) have been considered the gold standard imaging methods for diagnosing the morphological features of IPMN.<xref rid="deo2413-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> The most important finding in diagnosing high&#x02010;risk IPMNs is the presence of mural nodule (MN) or solid component (SC). MN is generally defined as a distinctly demarcated, elevated lesion within a cyst with contrast (existing blood flow) within the lesion on CT, MRI, or EUS, on the other hand, SC is defined as a substantial mass adjacent to the cyst wall and surrounding pancreatic parenchyma, and its finding suggests the presence of an invasive tumor, however, it is difficult to clearly differentiate between MN and SC.<xref rid="deo2413-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo2413-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo2413-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Kobayashi et&#x000a0;al. reported that MN size measured by EUS is useful in differentiating benign from malignant IPMNs. In this report, they found significant differences in MN height (4.3 mm for benign vs. 16.4 mm for malignant, <italic toggle="yes">p</italic> &#x0003c; 0.0001) and width (5.7 mm for benign vs. 23.2 mm for malignant, <italic toggle="yes">p</italic> &#x0003c; 0.001) of the papillary growth.<xref rid="deo2413-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Recent reports indicate that EUS (including contrast&#x02010;enhanced EUS [CE&#x02010;EUS]) is comparable or superior to MDCT and MRI in the diagnosis of high&#x02010;grade dysplasia (HGD) and invasive carcinoma (IC) in IPMN.<xref rid="deo2413-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="deo2413-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="deo2413-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="deo2413-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="deo2413-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="deo2413-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo2413-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="deo2413-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="deo2413-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="deo2413-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> (Table&#x000a0;<xref rid="deo2413-tbl-0001" ref-type="table">1</xref>) Several studies have been reported comparing the diagnostic performance of imaging modalities in the diagnosis of MN/SC in IPMN. For example, Huynh et&#x000a0;al. reported that MN diameter may be slightly overestimated by CT and MRI tomography and underestimated by EUS.<xref rid="deo2413-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Iwaya et&#x000a0;al. reported that septal wall thickness observed by EUS correlates with IPMN grade and that the area under the curve (AUC) for differential diagnosis between benign and malignant IPMN was 0.70 for EUS and 0.56 for MDCT, indicating that EUS is superior to MDCT.<xref rid="deo2413-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Shimizu et&#x000a0;al. considered EUS essential in the preoperative examination of IPMN because of its high spatial resolution, especially useful for the diagnosis of MPD dilatation and the presence of tiny papillary projections on the cyst wall or on the MPD.<xref rid="deo2413-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> They reported a simple nomogram for predicting HGD/IC based on three factors: MN diameter, cyst diameter, and MPD diameter. In this study, they employed MN/SC size measured using EUS and reported that the malignancy probability of IPMNs with findings of MN 5&#x02013;10 mm is less than 19%, while IPMNs with MN 10 mm or more have a malignancy probability increased to 67% by the MN factor findings alone.<xref rid="deo2413-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Kin et&#x000a0;al. compared preoperative CE&#x02010;CT and EUS MN detection rates using pathological findings as the gold standard.<xref rid="deo2413-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> This Japanese multicenter study enrolled 240 patients with pathological nodules. They could detect 83% of the MNs by EUS and only 53% by CT, concluding that EUS was significantly superior in detecting MNs. The average size of pathological MNs diagnosed by CT and EUS was 8 mm (range 1&#x02013;50 mm) for CT, 8 mm (range 2&#x02013;50 mm) for EUS, and 8 mm (range 3&#x02013;50 mm) for CT. range 1&#x02013;50 mm) and 6 mm (range 1&#x02013;50 mm) by EUS. These results suggest that EUS is a highly sensitive diagnostic tool that allows visualization of smaller MNs.</p><table-wrap position="float" id="deo2413-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Comparison of diagnostic performance of imaging modalities in the diagnosis of intraductal papillary mucinous neoplasms.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Author</th><th align="left" rowspan="1" colspan="1">Journal</th><th align="left" rowspan="1" colspan="1">Year</th><th align="left" rowspan="1" colspan="1">Comparison item</th><th align="left" rowspan="1" colspan="1">Result</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Nakagawa</td><td align="left" rowspan="1" colspan="1">Pancreas</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">Tumor detection</td><td align="left" rowspan="1" colspan="1">MD&#x02010;CT = EUS &#x0003e; SD&#x02010;CT</td></tr><tr><td align="left" rowspan="1" colspan="1">Harima</td><td align="left" rowspan="1" colspan="1">World J Gastroenterol</td><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">Mural nodule</td><td align="left" rowspan="1" colspan="1">EUS &#x0003e; CT = MRI</td></tr><tr><td align="left" rowspan="1" colspan="1">Kim</td><td align="left" rowspan="1" colspan="1">Pancreatology</td><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">Mural nodule</td><td align="left" rowspan="1" colspan="1">EUS = CT</td></tr><tr><td align="left" rowspan="1" colspan="1">Du</td><td align="left" rowspan="1" colspan="1">World J Gastroenterol</td><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">Detailed structure</td><td align="left" rowspan="1" colspan="1">EUS &#x0003e; CT, MRI</td></tr><tr><td align="left" rowspan="1" colspan="1">Ugbarugba</td><td align="left" rowspan="1" colspan="1">Pancreas</td><td align="left" rowspan="1" colspan="1">2018</td><td align="left" rowspan="1" colspan="1">Malignant potential</td><td align="left" rowspan="1" colspan="1">EUS &#x0003e; CT = MRI</td></tr><tr><td align="left" rowspan="1" colspan="1">Hwang</td><td align="left" rowspan="1" colspan="1">Eur Radiol</td><td align="left" rowspan="1" colspan="1">2018</td><td align="left" rowspan="1" colspan="1">Mural nodule</td><td align="left" rowspan="1" colspan="1">MRI &#x0003e; EUS</td></tr><tr><td align="left" rowspan="1" colspan="1">Iwaya</td><td align="left" rowspan="1" colspan="1">Dig Endosc</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">Thickness of septum</td><td align="left" rowspan="1" colspan="1">EUS &#x0003e; CT</td></tr><tr><td align="left" rowspan="1" colspan="1">Ohno</td><td align="left" rowspan="1" colspan="1">Pancreatology</td><td align="left" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">MPD involvement</td><td align="left" rowspan="1" colspan="1">EUS &#x0003e; CT</td></tr><tr><td align="left" rowspan="1" colspan="1">Kin</td><td align="left" rowspan="1" colspan="1">Pancreatology</td><td align="left" rowspan="1" colspan="1">2023</td><td align="left" rowspan="1" colspan="1">Mural nodule</td><td align="left" rowspan="1" colspan="1">EUS &#x0003e; CT</td></tr></tbody></table><table-wrap-foot><fn id="deo2413-tbl1-note-0001"><p>Abbreviations: CT, computed tomography; EUS, endoscopic ultrasonography; MPD, main pancreatic duct; MRI, magnetic resonance imaging.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo2413-sec-0040"><title>The advantages of CE&#x02010;EUS/contrast&#x02010;enhanced harmonic EUS in IPMN diagnostics</title><p>IPMN is a mucous&#x02010;producing tumor, and the mucous clots present in the cyst may be visualized as a polypoid mass. Distinguishing between a mucus clot and a true neoplastic nodule is essential for the assessment of the malignant potential of IPMN<xref rid="deo2413-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> (Figure&#x000a0;<xref rid="deo2413-fig-0002" ref-type="fig">2</xref>). &#x0201c;Enhancing MNs&#x0201d; is included in the HRS/worrisome features factor of the Kyoto guidelines.<xref rid="deo2413-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Historically, the diagnosis of enhancing MNs has been based on CE&#x02010;CT and contrast&#x02010;enhanced MRI findings. Recently, the use of CE&#x02010;EUS and contrast&#x02010;enhanced harmonic EUS (CH&#x02010;EUS) has been reported to differentiate between MN and mucus clots in PCLs<xref rid="deo2413-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="deo2413-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo2413-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>, <xref rid="deo2413-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="deo2413-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="deo2413-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="deo2413-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="deo2413-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref>, <xref rid="deo2413-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="deo2413-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="deo2413-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> (Table&#x000a0;<xref rid="deo2413-tbl-0002" ref-type="table">2</xref>). There are two viewing methods for CE&#x02010;EUS examinations.<xref rid="deo2413-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="deo2413-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>, <xref rid="deo2413-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>, <xref rid="deo2413-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref> One uses the &#x0201c;color Doppler mode&#x0201d; to observe the enhanced blood flow signal (CE&#x02010;EUS). This method can detect blood flow information in the region of interest with high sensitivity, but quantitative evaluation of blood flow information is not possible. The other method is the &#x0201c;contrast&#x02010;enhanced harmonic method&#x0201d;, and observes the increase in echo brightness due to the inflow of contrast agent (CH&#x02010;EUS). Time&#x02010;intensity curve analysis can be used for quantitative evaluation in CH&#x02010;EUS.</p><fig position="float" fig-type="FIGURE" id="deo2413-fig-0002"><label>FIGURE 2</label><caption><p>Contrast&#x02010;enhanced harmonic endoscopic ultrasonography (CH&#x02010;EUS) and contrast&#x02010;enhanced computed tomography (CE&#x02010;CT) for the diagnosis of mural nodules in intraductal papillary mucinous neoplasm (IPMN). (a) CT findings of mixed IPMN of the pancreatic head. The dilated main pancreatic duct and multilocular cystic lesions adjacent to the main pancreatic duct are seen. (b) CT findings of mixed IPMN of the pancreatic head. Septal structures are observed within multilocular cystic lesions. (c) CH&#x02010;EUS (before injection of Sonazoid). Right: reference B&#x02010;mode image, Left: contrast&#x02010;enhanced harmonic mode. The B&#x02010;mode and pre&#x02010;contrast harmonic EUS images show a hyperechoic polypoid lesion within the cyst. (d) CH&#x02010;EUS (after injection). Right: Reference B&#x02010;mode image; Left: Harmonic mode with contrast In CH&#x02010;EUS, the contrast effect is seen in the septal wall within the cyst and in the mural lesion, allowing the precise diagnosis of a mural nodule.</p></caption><graphic xlink:href="DEO2-5-e413-g002" position="anchor" id="jats-graphic-3"/></fig><table-wrap position="float" id="deo2413-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Diagnostic value of contrast&#x02010;enhanced endoscopic ultrasonography for intraductal papillary mucinous neoplasms (IPMNs).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Author</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="left" rowspan="1" colspan="1">Contrast agent</th><th align="left" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hirooka</td><td align="char" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">Albunex</td><td align="left" rowspan="1" colspan="1">Pattern diagnosis of PCLs, enhancement(+): SCN 3/3, mucinous cyst 6/8, and pseudocyst 0/5.</td></tr><tr><td align="left" rowspan="1" colspan="1">Hocke</td><td align="char" rowspan="1" colspan="1">125</td><td align="left" rowspan="1" colspan="1">SonoVue</td><td align="left" rowspan="1" colspan="1">Enhancement rate: Pseudocyst 6% (4/69) and cystic neoplasm 100% (56/56)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fusaroli</td><td align="char" rowspan="1" colspan="1">76</td><td align="left" rowspan="1" colspan="1">SonoVue</td><td align="left" rowspan="1" colspan="1">
<p>Hyperenhancement: Serous cyst (86%) and mucinous cyst (89%)</p>
<p>Hypoenhancement: Pseudocyst (90%)</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Kamata</td><td align="char" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">Differential diagnosis of serous and mucinous cyst: Fundamental EUS = CH&#x02010;EUS</td></tr><tr><td align="left" rowspan="1" colspan="1">Yamashita</td><td align="char" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">Diagnosis of MNs: CH&#x02010;EUS sensitivity 100%, specificity 80%, and accuracy 94%</td></tr><tr><td align="left" rowspan="1" colspan="1">Harima</td><td align="char" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">Detection of MNs: CH&#x02010;EUS 98% (MDCT 92% and fundamental EUS 72%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Yamamoto</td><td align="char" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">Malignant IPMNs by TIC analysis: higher echo intensity change, echo intensity reduction rate, and contrast ratio of the nodule/parenchyma.</td></tr><tr><td align="left" rowspan="1" colspan="1">Ohno</td><td align="char" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">Levovist/Sonazoid</td><td align="left" rowspan="1" colspan="1">Classification of MNs by CE&#x02010;EUS, type III or IV correlated malignancy</td></tr><tr><td align="left" rowspan="1" colspan="1">Fujita</td><td align="char" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">Use for differentiating between MNs and mucous lumps</td></tr><tr><td align="left" rowspan="1" colspan="1">Ohno</td><td align="char" rowspan="1" colspan="1">166</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">MPD involvement was diagnosed by CH&#x02010;EUS with a sensitivity of 83.5%, specificity of 87.0%, and accuracy of 84.9%. The accuracy of MPD involvement by EUS was superior to that of MPD size (84.9% vs. 71.7%).</td></tr><tr><td align="left" rowspan="1" colspan="1">Yamashita</td><td align="char" rowspan="1" colspan="1">115</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">
<p>Detection of mural lesion: CH&#x02010;EUS 92% and CT 72%;</p>
<p>Enhancement pattern is useful for the diagnosis of malignant IPMNs.</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Yashika</td><td align="char" rowspan="1" colspan="1">183</td><td align="left" rowspan="1" colspan="1">Sonazoid</td><td align="left" rowspan="1" colspan="1">Multiphase evaluation using CEH&#x02010;EUS is a useful method for differentiating between invasive IPMC and PDAC.</td></tr></tbody></table><table-wrap-foot><fn id="deo2413-tbl2-note-0001"><p>Abbreviations: CE&#x02010;EUS, contrast&#x02010;enhanced endoscopic ultrasonography; CH&#x02010;EUS, contrast&#x02010;enhanced harmonic endoscopic ultrasonography; IPMN, intraductal papillary mucinous neoplasm; MNs, mural nodules; MPD, main pancreatic duct; PCLs, pancreatic cystic lesions; PDAC, pancreatic ductal adenocarcinoma.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Ohno et&#x000a0;al. reported the morphologic classification of MNs based on CE&#x02010;EUS findings to exclude mucous clots. This study included 87 resected IPMNs. Type III (papillary nodule) and type IV (invasive nodule) MNs were associated with malignant IPMN in 88.9% and 91.7%, respectively. Multivariable logistic regression analysis showed that type III/IV MNs (odds ratio = 10.8; 95% confidence interval [CI] 2.75&#x02013;56.1) and symptomatic IPMNs (odds ratio = 4.31; 95% CI 1.37&#x02013;14.7) were significant for malignancy.<xref rid="deo2413-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Harima et&#x000a0;al. evaluated the role of CH&#x02010;EUS in the diagnosis of branch duct&#x02010;type IPMN (BD&#x02010;IPMN) in 50 resected cases. CE&#x02010;EUS was performed when mural lesions were detected on EUS. By EUS observation, 28 of 50 IPMNs had mural lesions, and 15 cases were diagnosed with MNs by CH&#x02010;EUS. The accuracy of CT, EUS alone, and EUS combined with CH&#x02010;EUS for diagnosing MNs was 92%, 72%, and 98%, respectively. They reported that MN height measured by CH&#x02010;EUS (with a cut&#x02010;off value of 6.8 mm) improved the accuracy of differential diagnosis of benign versus malignant BD&#x02010;IPMN.<xref rid="deo2413-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Yamashita et&#x000a0;al. compared the diagnostic performance of conventional EUS, CH&#x02010;EUS, and CE&#x02010;CT for the diagnosis of MN in IPMNs. CE&#x02010;CT had a sensitivity of 70%, specificity of 76%, and positive diagnosis rate of 83%, while CH&#x02010;EUS had a sensitivity of 97%, specificity of 76%, and positive diagnosis rate of 92%, indicating that CH&#x02010;EUS is superior in diagnosis.<xref rid="deo2413-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Additionally, it has been reported that CH&#x02010;EUS can observe and evaluate dynamic changes in contrast patterns in tumors and is useful for pathological grading of IPMN and differential diagnosis between IPMN&#x02010;derived cancer and pancreatic ductal adenocarcinoma (PDAC) by evaluating contrast patterns in MN/SC.<xref rid="deo2413-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="deo2413-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Yamamoto et&#x000a0;al. investigated CH&#x02010;EUS with time&#x02010;intensity curve analysis for MNs in 30 cases of resected IPMNs and suggested malignant IPMNs exhibited significantly higher echo intensity change, echo intensity reduction rate, and nodule/parenchyma contrast ratio.<xref rid="deo2413-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> Yashika et&#x000a0;al. compared the contrast enhancement findings in 42 invasive IPMC cases and 141 PDAC cases through multiphasic analysis. After propensity score matching for stage and solid tumor diameter, contrast enhancement patterns were significantly more persistent in invasive IPMC than in PDAC (<italic toggle="yes">p</italic> = 0.0013).<xref rid="deo2413-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>
</p><p>The malignancy rate of IPMN with MPD extension or involvement has been reported to be high. Marchegianni et&#x000a0;al. used reviewed MPD involving positive IPMN based on pathologic findings and compared with histopathologic findings. IPMNs involving MPD had the predominant intestinal epithelial phenotype and 72% of them were malignant.<xref rid="deo2413-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> In contrast to preoperative imaging, MPD involvement was defined by the diameter of the dilated MPD on preoperative imaging, mainly using CT or MRI. However, Crippa et&#x000a0;al. reported that assuming MPD involvement in IPMN solely based on observing MPD dilation by CT or MRI analysis carries the risk of misdiagnosis, as they found that 26% of IPMN cases with an MPD diameter of over 5 mm were not concordant with pathological MPD involvement. Therefore, they recommended careful follow&#x02010;up of patients with MPD 5&#x02013;9 mm because MPD dilatation in IPMN may be due to obstructive pancreatitis or secondary dilatation by mucinous masses.<xref rid="deo2413-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> Ohno et&#x000a0;al. classified MPD involvement into two definitions, one based on EUS findings of a low papillary lesion identified by CH&#x02010;EUS on MPD, and the other based on MPD size, and compared these definitions with pathologic findings. They concluded that MPD involvement based on EUS findings more accurately reflects pathological findings and can be a useful predictor of malignant IPMN.<xref rid="deo2413-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p></sec><sec id="deo2413-sec-0050"><title>Pathological diagnosis by EUS&#x02010;FNA and differential diagnosis of pancreatic cystic tumor by cystic fluid analysis</title><p>EUS&#x02010;FNA has been widely used in the pancreaticobiliary field, not only to obtain tissue for pathological diagnosis but also as an essential test for the practice of genomic medicine. EUS&#x02010;FNA for PCLs, especially IPMN, is recognized and practiced worldwide as a safe examination technique. The morbidity and mortality rates of EUS&#x02010;FNA for PCLs were 2.66% (95% CI 1.84&#x02013;3.62) and 0.19% (95% CI 0.09&#x02013;0.32), respectively.<xref rid="deo2413-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>, <xref rid="deo2413-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> In a prospective study of patients with pancreatic IPMN, Yoon et&#x000a0;al. compared the frequency of peritoneal seeding with and without preoperative EUS&#x02010;FNA in patients undergoing IPMN resection. The results showed no difference in the frequency of peritoneal dissemination between patients who underwent EUS&#x02010;FNA and those who did not and concluded that EUS&#x02010;FNA is a safe technique in the diagnosis of pancreatic cystic tumors.<xref rid="deo2413-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> However, there have been reports of needle tract seeding due to EUS&#x02010;FNA for cystic tumors, especially high&#x02010;grade lesions with MNs. Hirooka et&#x000a0;al. and Yamabe et&#x000a0;al. reported a case of needle tract seeding in patients with IPMC who underwent EUS&#x02010;FNA.<xref rid="deo2413-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="deo2413-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> The Kyoto Guidelines point out the risk of peritoneal dissemination with EUS&#x02010;FNA. If the imaging findings by MDCT/MRI clearly show HRS findings and surgery is considered to be indicated, EUS&#x02010;FNA should not be performed.<xref rid="deo2413-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>
</p><p>Regarding the diagnostic performance of cytological diagnosis using cystic fluid obtained by EUS&#x02010;FNA, a meta&#x02010;analysis showed that the sensitivity and specificity were 51% (95% CI 45%&#x02013;58%) and 94% (95% CI 92%&#x02013;96%), respectively (95% CI 92%&#x02013;96%).<xref rid="deo2413-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> Tanaka et&#x000a0;al. reported a sensitivity of 57%, specificity of 84%, and AUC of 0.82 for EUS&#x02010;FNA in the diagnosis of HGD/IC as a result of a systematic review.<xref rid="deo2413-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref> De Jong K et&#x000a0;al. reported that only one&#x02010;third of patients could obtain a sufficient sample volume for cytodiagnosis with EUS&#x02010;FNA. The low number of tumor cells in the cystic fluid is thought to be a contributing factor, and various tissue sampling methods have been reported to overcome this drawback.<xref rid="deo2413-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> Recently, EUS&#x02010;guided through&#x02010;the&#x02010;needle biopsy (EUS&#x02010;TTNB) has been reported, in which biopsy forceps are inserted through the lumen of the EUS&#x02010;FNA needle to perform cyst wall biopsy. Tacelli et&#x000a0;al. reported a positive diagnosis rate of 86.7% for EUS&#x02010;TTNB in pancreatic cystic tumors, but an incidental complication was observed in 8.6% of cases.<xref rid="deo2413-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> Shi&#x02010;yu et&#x000a0;al. compared the diagnostic performance of EUS&#x02010;related procedures for pancreatic cystic tumors using a network meta&#x02010;analysis approach.<xref rid="deo2413-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref> The results showed that EUS&#x02010;TTNB had a sensitivity of 0.87 and specificity of 0.83 for the diagnosis of mucinous PCL, and a sensitivity of 0.97 and specificity of 0.95 for the diagnosis of malignant PCL. On the other hand, EUS&#x02010;TTNB is associated with incidental findings such as intracystic hemorrhage and pancreatitis, which occurred in 0%&#x02013;22.9% of cases.</p><p>The analysis of cystic fluid for molecular markers and gene profiling including pancreatic enzymes and carcinoembryonic antigen (CEA) in cystic fluid has been found useful in the differential diagnosis of PCLs.<xref rid="deo2413-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>, <xref rid="deo2413-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>, <xref rid="deo2413-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref>, <xref rid="deo2413-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> The CEA level in a cystic fluid is higher in mucinous cysts, and in the differential diagnosis of IPMN between benign and malignant tumors, the sensitivity and specificity were reported to be 90% and 71%, respectively, when CEA &#x0003e;200 ng/mL was used as the cutoff and 87.5% sensitivity and 73% specificity when CA72&#x02010;4 &#x0003e;40 U/mL was used as the cutoff. However, the cutoff values for tumor marker levels in pancreatic cysts vary among reports.</p><p>In recent years, the usefulness of gene profiling in cystic fluid as a liquid biopsy using cystic fluid has also been reported. Detection of <italic toggle="yes">KRAS</italic> and <italic toggle="yes">GNAS</italic> mutations in cystic fluid has been reported to have a sensitivity of 79% and specificity of 98% for the diagnosis of mucinous cysts as a useful tool in the differential diagnosis of PCLs.<xref rid="deo2413-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref>, <xref rid="deo2413-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="deo2413-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref>, <xref rid="deo2413-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> In the diagnosis of high&#x02010;grade IPMN (HGD/IC), evaluation of <italic toggle="yes">TP53, SMAD4, CDKN2A</italic>, and <italic toggle="yes">PIK3CA</italic> mutations, which are also relatively common in PDAC, is useful in identifying the presence of HGD/IC with low sensitivity (3%&#x02013;39%) but high specificity (92%&#x02013;98%).<xref rid="deo2413-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref>
</p><p>In summary, EUS&#x02010;FNA is useful for analyzing pancreatic cystic tumors, but because of some risk of needle tract seeding, the technique should only be performed if the test results are useful in determining the patient's treatment strategy.</p></sec></sec><sec id="deo2413-sec-0060"><title>FUTURE PERSPECTIVES</title><p>EUS is a diagnostic imaging method with high spatial resolution, but it may have a weakness in that the obtained image findings and diagnostic imaging decisions depend on the surgeon and lack objectivity. Machine learning using artificial intelligence, which has been advancing rapidly in recent years, maybe a solution to this problem. For the differential diagnosis between benign and malignant IPMN using EUS images, the usefulness of deep learning for overcoming poor objectivity has already been reported.<xref rid="deo2413-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref>, <xref rid="deo2413-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref> Schulz et&#x000a0;al. performed machine learning using 3355 EUS images from 43 patients. The diagnostic performance of AI for high&#x02010;grade IPMN/Invasive carcinoma was reported to be 100% sensitivity, 99.7% specificity, and 99.6% positive predictive value, which is significantly superior to the predictive performance of various IPMN guidelines.<xref rid="deo2413-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref> However, even with advances in AI diagnostic technology, it is essential for endoscopists to have knowledge of appropriate EUS maneuvers and ultrasound imaging in order to use the full potential of EUS imaging and EUS&#x02010;FNA procedures.</p></sec><sec sec-type="COI-statement" id="deo2413-sec-0070"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo2413-sec-0080"><title>ETHICS STATEMENT</title><p>As this article is a review article based on published literature, no ethics approval was required.</p></sec><sec id="deo2413-sec-0090"><p>&#x02010;Approval of the research protocol by an Institutional Reviewer Board. N/A</p></sec><sec id="deo2413-sec-0100"><p>&#x02010;Informed Consent. N/A</p></sec><sec id="deo2413-sec-0110"><p>&#x02010;Registry and the Registration No. of the study/trial. N/A</p></sec><sec id="deo2413-sec-0120"><p>&#x02010;Animal Studies. N/A</p></sec></body><back><ref-list id="deo2413-bibl-0001"><title>REFERENCES</title><ref id="deo2413-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo2413-cit-0001">
<string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hirooka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fujishiro</surname>
<given-names>M</given-names>
</string-name>. <article-title>Endoscopic ultrasonography for the evaluation of pancreatic cystic neoplasms</article-title>. <source>J Med Ultrason</source>
<year>2020</year>; <volume>47</volume>: <fpage>401</fpage>&#x02013;<lpage>411</lpage>
</mixed-citation></ref><ref id="deo2413-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo2413-cit-0002">
<string-name>
<surname>Ohtsuka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fernandez&#x02010;Del Castillo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Furukawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>International evidence&#x02010;based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas</article-title>. <source>Pancreatology</source>
<year>2024</year>; <volume>24</volume>: <fpage>255</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">38182527</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo2413-cit-0003">
<collab collab-type="authors">European Study Group on Cystic Tumours of the Pancreas</collab>
. <article-title>European evidence&#x02010;based guidelines on pancreatic cystic neoplasms</article-title>. <source>Gut</source>
<year>2018</year>; <volume>67</volume>: <fpage>789</fpage>&#x02013;<lpage>804</lpage>.<pub-id pub-id-type="pmid">29574408</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo2413-cit-0004">
<string-name>
<surname>Vege</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Ziring</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Moayyedi</surname>
<given-names>P</given-names>
</string-name>. <article-title>American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts</article-title>. <source>Gastroenterology</source>
<year>2015</year>; <volume>148</volume>: <fpage>819</fpage>&#x02013;<lpage>822</lpage>.<pub-id pub-id-type="pmid">25805375</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo2413-cit-0005">
<string-name>
<surname>Tada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kawabe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Arizumi</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Pancreatic cancer in patients with pancreatic cystic lesions: A prospective study in 197 patients</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2006</year>; <volume>4</volume>: <fpage>1265</fpage>&#x02013;<lpage>1270</lpage>.<pub-id pub-id-type="pmid">16979953</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo2413-cit-0006">
<string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Itoh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Malignant transformation of branch duct&#x02010;type intraductal papillary mucinous neoplasms of the pancreas based on contrast&#x02010;enhanced endoscopic ultrasonography morphological changes: Focus on malignant transformation of intraductal papillary mucinous neoplasm itself</article-title>. <source>Pancreas</source>
<year>2012</year>; <volume>41</volume>: <fpage>855</fpage>&#x02013;<lpage>862</lpage>.<pub-id pub-id-type="pmid">22481289</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo2413-cit-0007">
<string-name>
<surname>Kamata</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kitano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kudo</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms</article-title>. <source>Endoscopy</source>
<year>2014</year>; <volume>46</volume>: <fpage>22</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">24218310</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo2413-cit-0008">
<string-name>
<surname>Oyama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takagi</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Long&#x02010;term risk of malignancy in branch&#x02010;duct intraductal papillary mucinous neoplasms</article-title>. <source>Gastroenterology</source>
<year>2020</year>; <volume>158</volume>: <fpage>226</fpage>&#x02013;<lpage>237</lpage>.<pub-id pub-id-type="pmid">31473224</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo2413-cit-0009">
<string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hashimoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hirooka</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Current status of tissue harmonic imaging in endoscopic ultrasonography (EUS) and EUS&#x02010;elastography in pancreatobiliary diseases</article-title>. <source>Dig Endosc</source>
<year>2015</year>; <volume>27</volume>: <fpage>68</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">25630752</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo2413-cit-0010">
<string-name>
<surname>Vilmann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hancke</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Henriksen</surname>
<given-names>FW</given-names>
</string-name>, <string-name>
<surname>Jacobsen</surname>
<given-names>GK</given-names>
</string-name>. <article-title>Endosonographically&#x02010;guided fine needle aspiration biopsy of malignant lesions in the upper gastrointestinal tract</article-title>. <source>Endoscopy</source>
<year>1993</year>; <volume>25</volume>: <fpage>523</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">8287813</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo2413-cit-0011">
<string-name>
<surname>Ikeda</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hijioka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nagashio</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Fine&#x02010;needle biopsy with 19G needle is effective in combination with endoscopic ultrasound&#x02010;guided tissue acquisition for genomic profiling of unresectable pancreatic cancer</article-title>. <source>Dig Endosc</source>
<year>2023</year>; <volume>35</volume>: <fpage>124</fpage>&#x02013;<lpage>133</lpage>.<pub-id pub-id-type="pmid">35993898</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo2413-cit-0012">
<string-name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fern&#x000e1;ndez&#x02010;Del Castillo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kamisawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas</article-title>. <source>Pancreatology</source>
<year>2017</year>; <volume>17</volume>: <fpage>738</fpage>&#x02013;<lpage>753</lpage>.<pub-id pub-id-type="pmid">28735806</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo2413-cit-0013">
<string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Balduzzi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hijioka</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Association of high&#x02010;risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review</article-title>. <source>Pancreatology</source>
<year>2024</year>; <volume>24</volume>: <fpage>48</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">38161091</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo2413-cit-0014">
<string-name>
<surname>Kobayashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Sugimori</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shimamura</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas</article-title>. <source>Pancreatology</source>
<year>2012</year>; <volume>12</volume>: <fpage>141</fpage>&#x02013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">22487524</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo2413-cit-0015">
<string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Hirooka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Itoh</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Intraductal papillary mucinous neoplasms of the pancreas: Differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules</article-title>. <source>Ann Surg</source>
<year>2009</year>; <volume>249</volume>: <fpage>628</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">19300203</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo2413-cit-0016">
<string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Can contrast&#x02010;enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?</article-title>
<source>Pancreatology</source>
<year>2020</year>; <volume>20</volume>: <fpage>887</fpage>&#x02013;<lpage>894</lpage>.<pub-id pub-id-type="pmid">32651080</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo2413-cit-0017">
<string-name>
<surname>Iwaya</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hijioka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched&#x02010;duct and mixed&#x02010;type intraductal papillary mucinous neoplasm of the pancreas</article-title>. <source>Dig Endosc</source>
<year>2019</year>; <volume>31</volume>: <fpage>672</fpage>&#x02013;<lpage>681</lpage>.<pub-id pub-id-type="pmid">30920028</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo2413-cit-0018">
<string-name>
<surname>Ugbarugba</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Grieco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>PA</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Diagnostic accuracy of preoperative imaging for differentiation of branch duct versus mixed duct intraductal papillary mucinous neoplasms</article-title>. <source>Pancreas</source>
<year>2018</year>; <volume>47</volume>: <fpage>556</fpage>&#x02013;<lpage>560</lpage>.<pub-id pub-id-type="pmid">29683969</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo2413-cit-0019">
<string-name>
<surname>Kim</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Hwang</surname>
<given-names>JH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study</article-title>. <source>Pancreatology</source>
<year>2015</year>; <volume>15</volume>: <fpage>405</fpage>&#x02013;<lpage>410</lpage>.<pub-id pub-id-type="pmid">25998516</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo2413-cit-0020">
<string-name>
<surname>Harima</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kaino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shinoda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kawano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Suenaga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sakaida</surname>
<given-names>I</given-names>
</string-name>. <article-title>Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast&#x02010;enhanced endoscopic ultrasonography</article-title>. <source>World J Gastroenterol</source>
<year>2015</year>; <volume>21</volume>: <fpage>6252</fpage>&#x02013;<lpage>6260</lpage>.<pub-id pub-id-type="pmid">26034360</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo2413-cit-0021">
<string-name>
<surname>Nakagawa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yamaguchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ohtsuka</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single&#x02010;detector computed tomography and endoscopic ultrasonography</article-title>. <source>Pancreas</source>
<year>2009</year>; <volume>38</volume>: <fpage>131</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">18981954</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo2413-cit-0022">
<string-name>
<surname>Du</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chai</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Linghu</surname>
<given-names>EQ</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparison of endoscopic ultrasound, computed tomography and magnetic resonance imaging in assessment of detailed structures of pancreatic cystic neoplasms</article-title>. <source>World J Gastroenterol</source>
<year>2017</year>; <volume>23</volume>: <fpage>3184</fpage>&#x02013;<lpage>3192</lpage>.<pub-id pub-id-type="pmid">28533675</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo2413-cit-0023">
<string-name>
<surname>Hwang</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JE</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Pre&#x02010;operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: Focused on imaging features based on revised international guideline</article-title>. <source>Eur Radiol</source>
<year>2020</year>; <volume>30</volume>: <fpage>3711</fpage>&#x02013;<lpage>3722</lpage>.<pub-id pub-id-type="pmid">32095876</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo2413-cit-0024">
<string-name>
<surname>Kin</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hijioka</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A comparative study between computed tomography and endoscopic ultrasound in the detection of a mural nodule in intraductal papillary mucinous neoplasm &#x02013; Multicenter observational study in Japan</article-title>. <source>Pancreatology</source>
<year>2023</year>; <volume>23</volume>: <fpage>550</fpage>&#x02013;<lpage>555</lpage>.<pub-id pub-id-type="pmid">37286439</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo2413-cit-0025">
<string-name>
<surname>Huynh</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Vyas</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparison of imaging modalities for measuring the diameter of intraductal papillary mucinous neoplasms of the pancreas</article-title>. <source>Pancreatology</source>
<year>2020</year>; <volume>20</volume>: <fpage>448</fpage>&#x02013;<lpage>453</lpage>.<pub-id pub-id-type="pmid">32113936</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo2413-cit-0026">
<string-name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hijioka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hirono</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>New model for predicting malignancy in patients with intraductal papillary mucinous neoplasm</article-title>. <source>Ann Surg</source>
<year>2020</year>; <volume>272</volume>: <fpage>155</fpage>&#x02013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">30499803</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo2413-cit-0027">
<string-name>
<surname>Hirooka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Contrast&#x02010;enhanced endoscopic ultrasonography in pancreatic diseases: A preliminary study</article-title>. <source>Am J Gastroenterol</source>
<year>1998</year>; <volume>93</volume>: <fpage>632</fpage>&#x02013;<lpage>635</lpage>.<pub-id pub-id-type="pmid">9576461</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo2413-cit-0028">
<string-name>
<surname>Hocke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cui</surname>
<given-names>XW</given-names>
</string-name>, <string-name>
<surname>Domagk</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ignee</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dietrich</surname>
<given-names>CF</given-names>
</string-name>. <article-title>Pancreatic cystic lesions: The value of contrast&#x02010;enhanced endoscopic ultrasound to influence the clinical pathway</article-title>. <source>Endosc Ultrasound</source>
<year>2014</year>; <volume>3</volume>: <fpage>123</fpage>&#x02013;<lpage>1230</lpage>.<pub-id pub-id-type="pmid">24955342</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="deo2413-cit-0029">
<string-name>
<surname>Fusaroli</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Serrani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Giorgio</surname>
<given-names>RD</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Contrast harmonic&#x02010;endoscopic ultrasound is useful to identify neoplastic features of pancreatic cysts (with videos)</article-title>. <source>Pancreas</source>
<year>2016</year>; <volume>45</volume>: <fpage>265</fpage>&#x02013;<lpage>268</lpage>.<pub-id pub-id-type="pmid">26474428</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="deo2413-cit-0030">
<string-name>
<surname>Kamata</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kitano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Omoto</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Contrast&#x02010;enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts</article-title>. <source>Endoscopy</source>
<year>2016</year>; <volume>48</volume>: <fpage>35</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">26605974</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="deo2413-cit-0031">
<string-name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ueda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Itonaga</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Tumor vessel depiction with contrast&#x02010;enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer</article-title>. <source>Pancreas</source>
<year>2013</year>; <volume>42</volume>: <fpage>990</fpage>&#x02013;<lpage>995</lpage>.<pub-id pub-id-type="pmid">23851433</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="deo2413-cit-0032">
<string-name>
<surname>Yamamoto</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tomoda</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Contrast&#x02010;enhanced harmonic endoscopic ultrasonography with time&#x02010;intensity curve analysis for intraductal papillary mucinous neoplasms of the pancreas</article-title>. <source>Endoscopy</source>
<year>2016</year>; <volume>48</volume>: <fpage>26</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">26561919</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="deo2413-cit-0033">
<string-name>
<surname>Fujita</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Itoi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ikeuchi</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Effectiveness of contrast&#x02010;enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions</article-title>. <source>Endosc Ultrasound</source>
<year>2016</year>; <volume>5</volume>: <fpage>377</fpage>&#x02013;<lpage>383</lpage>.<pub-id pub-id-type="pmid">28000629</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="deo2413-cit-0034">
<string-name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kawaji</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shimokawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Usefulness of contrast&#x02010;enhanced harmonic endoscopic ultrasonography for diagnosis of malignancy in intraductal papillary mucinous neoplasm</article-title>. <source>Diagnostics</source>
<year>2022</year>; <volume>12</volume>: <fpage>2141</fpage>.<pub-id pub-id-type="pmid">36140542</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="deo2413-cit-0035">
<string-name>
<surname>Yashika</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ohno</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Utility of multiphase contrast enhancement patterns on CEH&#x02010;EUS for the differential diagnosis of IPMN&#x02010;derived and conventional pancreatic cancer</article-title>. <source>Pancreatology</source>
<year>2021</year>; <volume>21</volume>: <fpage>390</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">33487577</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="deo2413-cit-0036">
<string-name>
<surname>Hirooka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Itoh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Contrast&#x02010;enhanced endoscopic ultrasonography in digestive diseases</article-title>. <source>J Gastroenterol</source>
<year>2012</year>; <volume>47</volume>: <fpage>1063</fpage>&#x02013;<lpage>1072</lpage>.<pub-id pub-id-type="pmid">23001249</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="deo2413-cit-0037">
<string-name>
<surname>Kitano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kamata</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>The Asian Federation of Societies for Ultrasound in Medicine and Biology (AFSUMB) guidelines for contrast&#x02010;enhanced endoscopic ultrasound</article-title>. <source>Ultrasound Med Biol</source>
<year>2021</year>; <volume>47</volume>: <fpage>1433</fpage>&#x02013;<lpage>1447</lpage>.<pub-id pub-id-type="pmid">33653627</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="deo2413-cit-0038">
<string-name>
<surname>Kitano</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kudo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamao</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Characterization of small solid tumors in the pancreas: The value of contrast&#x02010;enhanced harmonic endoscopic ultrasonography</article-title>. <source>Am J Gastroenterol</source>
<year>2012</year>; <volume>107</volume>: <fpage>303</fpage>&#x02013;<lpage>310</lpage>.<pub-id pub-id-type="pmid">22008892</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="deo2413-cit-0039">
<string-name>
<surname>Yamamoto</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tomoda</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Contrast&#x02010;enhanced harmonic endoscopic ultrasonography with time&#x02010;intensity curve analysis for intraductal papillary mucinous neoplasms of the pancreas</article-title>. <source>Endoscopy</source>
<year>2016</year>; <volume>48</volume>: <fpage>26</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">26561919</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="deo2413-cit-0040">
<string-name>
<surname>Marchegiani</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mino&#x02010;Kenudson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sahora</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>IPMN involving the main pancreatic duct: Biology, epidemiology, and long&#x02010;term outcomes following resection</article-title>. <source>Ann Surg</source>
<year>2015</year>; <volume>261</volume>: <fpage>976</fpage>&#x02013;<lpage>983</lpage>.<pub-id pub-id-type="pmid">24979607</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="deo2413-cit-0041">
<string-name>
<surname>Crippa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pergolini</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Rubini</surname>
<given-names>C</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main&#x02010;duct intraductal papillary mucinous neoplasms</article-title>. <source>Surgery</source>
<year>2016</year>; <volume>159</volume>: <fpage>1041</fpage>&#x02013;<lpage>1049</lpage>.<pub-id pub-id-type="pmid">26704784</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="deo2413-cit-0042">
<string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Assessment of morbidity and mortality associated with endoscopic ultrasound&#x02010;guided fine&#x02010;needle aspiration for pancreatic cystic lesions: A systematic review and meta&#x02010;analysis</article-title>. <source>Dig Endosc</source>
<year>2017</year>; <volume>29</volume>: <fpage>667</fpage>&#x02013;<lpage>675</lpage>.<pub-id pub-id-type="pmid">28218999</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="deo2413-cit-0043">
<string-name>
<surname>Yoon</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Daglilar</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Fern&#x000e1;ndez&#x02010;del Castillo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mino&#x02010;Kenudson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pitman</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Brugge</surname>
<given-names>WR</given-names>
</string-name>. <article-title>Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound&#x02010;guided fine&#x02010;needle aspiration: The PIPE Study</article-title>. <source>Endoscopy</source>
<year>2014</year>; <volume>46</volume>: <fpage>382</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="pmid">24619804</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="deo2413-cit-0044">
<string-name>
<surname>Hirooka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Itoh</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Case of intraductal papillary mucinous tumor in which endosonography&#x02010;guided fine&#x02010;needle aspiration biopsy caused dissemination</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2003</year>; <volume>18</volume>: <fpage>1323</fpage>&#x02013;<lpage>1324</lpage>.<pub-id pub-id-type="pmid">14535994</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="deo2413-cit-0045">
<string-name>
<surname>Yamabe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Irisawa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shibukawa</surname>
<given-names>G</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Rare condition of needle tract seeding after EUS&#x02010;guided FNA for intraductal papillary mucinous carcinoma</article-title>. <source>Endosc Int Open</source>
<year>2016</year>; <volume>4</volume>: <fpage>E756</fpage>&#x02013;<lpage>E758</lpage>.<pub-id pub-id-type="pmid">27556091</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="deo2413-cit-0046">
<string-name>
<surname>Wang</surname>
<given-names>QX</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Orange</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>YQ</given-names>
</string-name>. <article-title>EUS&#x02010;guided FNA for diagnosis of pancreatic cystic lesions: A meta&#x02010;analysis</article-title>. <source>Cell Physiol Biochem</source>
<year>2015</year>; <volume>36</volume>: <fpage>1197</fpage>&#x02013;<lpage>1209</lpage>.<pub-id pub-id-type="pmid">26138881</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="deo2413-cit-0047">
<string-name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Heckler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Heger</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Hackert</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Michalski</surname>
<given-names>CW</given-names>
</string-name>. <article-title>Cytologic analysis of pancreatic juice increases specificity of detection of malignant IPMN&#x02013;A systematic review</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2019</year>; <volume>17</volume>: <fpage>2199</fpage>&#x02013;<lpage>2211</lpage>. 48.<pub-id pub-id-type="pmid">30630102</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="deo2413-cit-0048">
<string-name>
<surname>de Jong</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Poley</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>van Hooft</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Visser</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Fockens</surname>
<given-names>P</given-names>
</string-name>. <article-title>Endoscopic ultrasound&#x02010;guided fine&#x02010;needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: Initial results from a prospective study</article-title>. <source>Endoscopy</source>
<year>2011</year>; <volume>43</volume>: <fpage>585</fpage>&#x02013;<lpage>590</lpage>.<pub-id pub-id-type="pmid">21611945</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="deo2413-cit-0049">
<string-name>
<surname>Tacelli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Celsa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Magro</surname>
<given-names>B</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Diagnostic performance of endoscopic ultrasound through&#x02010;the&#x02010;needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta&#x02010;analysis</article-title>. <source>Dig Endosc</source>
<year>2020</year>; <volume>32</volume>: <fpage>1018</fpage>&#x02013;<lpage>1030</lpage>.<pub-id pub-id-type="pmid">31912580</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="deo2413-cit-0050">
<string-name>
<surname>Li</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>ZJ</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>CY</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Comparative performance of endoscopic ultrasound&#x02010;based techniques in patients with pancreatic cystic lesions: A network meta&#x02010;analysis</article-title>. <source>Am J Gastroenterol</source>
<year>2023</year>; <volume>118</volume>: <fpage>243</fpage>&#x02013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">36563321</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="deo2413-cit-0051">
<string-name>
<surname>Frossard</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Amouyal</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Amouyal</surname>
<given-names>G</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Performance of endosonography&#x02010;guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions</article-title>. <source>Am J Gastroenterol</source>
<year>2003</year>; <volume>98</volume>: <fpage>1516</fpage>&#x02013;<lpage>1524</lpage>.<pub-id pub-id-type="pmid">12873573</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="deo2413-cit-0052">
<string-name>
<surname>Maire</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Voitot</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Aubert</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy</article-title>. <source>Am J Gastroenterol</source>
<year>2008</year>; <volume>103</volume>: <fpage>2871</fpage>&#x02013;<lpage>2877</lpage>.<pub-id pub-id-type="pmid">18775021</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="deo2413-cit-0053">
<string-name>
<surname>van der Waaij</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>van Dullemen</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Porte</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: A pooled analysis</article-title>. <source>Gastrointest Endosc</source>
<year>2005</year>; <volume>62</volume>: <fpage>383</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">16111956</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="deo2413-cit-0054">
<string-name>
<surname>Pfl&#x000fc;ger</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Jamouss</surname>
<given-names>KT</given-names>
</string-name>, <string-name>
<surname>Afghani</surname>
<given-names>E</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta&#x02010;analysis</article-title>. <source>Pancreatology</source>
<year>2023</year>; <volume>23</volume>: <fpage>868</fpage>&#x02013;<lpage>877</lpage>.<pub-id pub-id-type="pmid">37230894</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="deo2413-cit-0055">
<string-name>
<surname>Singhi</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Nikiforova</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Fasanella</surname>
<given-names>KE</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts</article-title>. <source>Clin Cancer Res</source>
<year>2014</year>; <volume>20</volume>: <fpage>4381</fpage>&#x02013;<lpage>4389</lpage>.<pub-id pub-id-type="pmid">24938521</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="deo2413-cit-0056">
<string-name>
<surname>Springer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dal Molin</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A combination of molecular markers and clinical features improve the classification of pancreatic cysts</article-title>. <source>Gastroenterology</source>
<year>2015</year>; <volume>149</volume>: <fpage>1501</fpage>&#x02013;<lpage>1510</lpage>.<pub-id pub-id-type="pmid">26253305</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="deo2413-cit-0057">
<string-name>
<surname>Singhi</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>McGrath</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brand</surname>
<given-names>RE</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Preoperative next&#x02010;generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia</article-title>. <source>Gut</source>
<year>2018</year>; <volume>67</volume>: <fpage>2131</fpage>&#x02013;<lpage>2141</lpage>.<pub-id pub-id-type="pmid">28970292</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="deo2413-cit-0058">
<string-name>
<surname>Springer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Masica</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Dal Molin</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>A multimodality test to guide the management of patients with a pancreatic cyst</article-title>. <source>Sci Transl Med</source>
<year>2019</year>; <volume>11</volume>: <elocation-id>eaav4772</elocation-id>.<pub-id pub-id-type="pmid">31316009</pub-id>
</mixed-citation></ref><ref id="deo2413-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="deo2413-cit-0059">
<string-name>
<surname>Kuwahara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>N</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Usefulness of deep learning analysis for the diagnosis of malignancy in intraductal papillary mucinous neoplasms of the pancreas</article-title>. <source>Clin Transl Gastroenterol</source>
<year>2019</year>; <volume>10</volume>: <fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="deo2413-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="deo2413-cit-0060">
<string-name>
<surname>Schulz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Heilmaier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Phillip</surname>
<given-names>V</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Accurate prediction of histological grading of intraductal papillary mucinous neoplasia using deep learning</article-title>. <source>Endoscopy</source>
<year>2023</year>; <volume>55</volume>: <fpage>415</fpage>&#x02013;<lpage>422</lpage>.<pub-id pub-id-type="pmid">36323331</pub-id>
</mixed-citation></ref></ref-list></back></article>